Ophthalmology

Data show full complement ST266 biologic offers better neuroprotection than fractionated formats

Roche's faricimab injected every 16 weeks proves non-inferior to aflibercept injected every eight weeks in patients with “wet” age-related macular degeneration

The acquisition includes clinical stage anti-IGF-1R monoclonal antibody VRDN-001, which is intended for treatment of thyroid eye disease

Vanda Pharmaceuticals gains FDA approval on their IND for VSJ-110 to treat allergic conjunctivitis

Astrocytes could play a critical role in nerve death in neurodegenerative diseases

San Diego Academy of Regenerative Therapies publishes article about first-in-human clinical trial using adipose-derived SVF to treat post-COVID-19 patients suffering lung damage

ADVM-022 demonstrates efficacy, durability in OPTIC trial in wet AMD

ProQR offers upbeat interim analysis in Phase 1/2 trial of QR-421a for Usher Syndrome

Ocugen’s gene therapy candidate shows potential in five different models of retinitis pigmentosa